Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Belgium.
Nuclear Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Z Med Phys. 2023 Feb;33(1):103-113. doi: 10.1016/j.zemedi.2022.08.003. Epub 2022 Sep 24.
We present guidelines by the European Association of Nuclear Medicine (EANM) for routine quality control (QC) of PET-CT and PET-MR systems. These guidelines are partially based on the current EANM guidelines for routine quality control of Nuclear Medicine instrumentation but focus more on the inherent multimodal aspect of the current, state-of-the-art PET-CT and PET-MR scanners. We briefly discuss the regulatory context put forward by the International Electrotechnical Commission (IEC) and European Commission (EC) and consider relevant guidelines and recommendations by other societies and professional organizations. As such, a comprehensive overview of recommended quality control procedures is provided to ensure the optimal operational status of a PET system, integrated with either a CT or MR system. In doing so, we also discuss the rationale of the different tests, advice on the frequency of each test and present the relevant MR and CT tests for an integrated system. In addition, we recommend a scheme of preventive actions to avoid QC tests from drifting out of the predefined range of acceptable performance values such that an optimal performance of the PET system is maintained for routine clinical use.
我们提出了欧洲核医学协会(EANM)的 PET-CT 和 PET-MR 系统常规质量控制(QC)指南。这些指南部分基于当前 EANM 核医学仪器常规质量控制指南,但更侧重于当前最先进的 PET-CT 和 PET-MR 扫描仪的固有多模态方面。我们简要讨论了国际电工委员会(IEC)和欧洲委员会(EC)提出的监管背景,并考虑了其他学会和专业组织的相关指南和建议。因此,提供了推荐的质量控制程序的综合概述,以确保与 CT 或 MR 系统集成的 PET 系统处于最佳运行状态。在这样做的过程中,我们还讨论了不同测试的基本原理、关于每个测试频率的建议,并为集成系统提供了相关的 MR 和 CT 测试。此外,我们建议采取预防措施的方案,以避免 QC 测试超出可接受性能值的预定义范围,从而为常规临床使用维持 PET 系统的最佳性能。